News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Jubilant to expand campus with $18.5M allergens facility
Jubilant HollisterStier plans to expand its Spokane campus with a new $18.5 million building to relocate its allergens processing business unit. The proposed two-story structure

Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
InduPro has entered a collaboration with Eli Lilly to discover new cancer treatments through a deal that could be worth up to $950 million. Under

Variant Bio launches AI-powered platform for drug discovery using genetic data
Variant Bio has launched an AI-powered platform designed to discover new drug candidates using human genetic data. The private biotech company said its Inference platform

Seattle-area nuclear company TerraPower signs deal with Meta for up to 8 reactors
Bellevue-based TerraPower announced a deal with Meta to build up to eight small modular nuclear reactors in the U.S. to supply clean energy for the

Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics
Seattle-based Alpenglow Biosciences announced a partnership with PathNet to bring its 3D microscope technology into clinical pathology labs to modernize diagnostics for prostate and bladder

Scientists develop new way to “listen in” on the brain’s hidden language
Scientists at the Allen Institute and HHMI’s Janelia Research Campus engineered a protein that can record the incoming chemical signals of brain cells, enabling researchers

Adaptive Signs Deal with Pfizer Worth Up to $890M for Rheumatoid Arthritis Research
Adaptive Biotechnologies announced two non-exclusive agreements with Pfizer to advance immune receptor discovery and data access. Pfizer will use Adaptive’s platform to identify disease-driving T-cell

Ex-Amazon AI engineer bets six figures of his own money to disrupt drug discovery
Seattle startup Rhizome Research is building AI systems to design made-to-order small drug-like molecules for drug discovery. Founded by former Amazon AI engineer Xhuliano Brace,

Athira Pharma raises $90 million as Bothell firm shifts focus
Bothell-based Athira Pharma is raising $90 million as it shifts its primary focus from neurological diseases to breast cancer. The company announced a $90 million

‘Scientist-as-a-Service’: Seattle startup Pauling.AI aims to shrink drug discovery timelines by months
Seattle-area startup Pauling.AI is using artificial intelligence to automate early drug discovery steps, reducing processes that once took three to six months down to weeks.

Seattle startup Casera emerges from PSL to help hospital managers clear bottlenecks with help from AI
Seattle-based startup Casera is emerging from Pioneer Square Labs with an AI-powered software platform designed to automate case management tasks and support patient flow

Microsoft, Providence and UW create AI that unlocks tumor insights at a scale previously out of reach
Researchers from Microsoft, Providence, and the University of Washington’s Paul G. Allen School of Computer Science and Engineering have developed an AI model that generates
